Entheon Biomedical Corp. (ENBI.CN)
Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
At close: 01:07PM EDT
Currency in CAD
Valuation Measures4
| Market Cap (intraday) | 886.34k |
| Enterprise Value | 541.71k |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.54 |
| Price/Book (mrq) | 2.81 |
| Enterprise Value/Revenue | 2.16 |
| Enterprise Value/EBITDA | -1.73 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.50 |
| 52-Week Change 3 | -40.00% |
| S&P500 52-Week Change 3 | 21.61% |
| 52 Week High 3 | 0.3500 |
| 52 Week Low 3 | 0.0000 |
| 50-Day Moving Average 3 | 0.1227 |
| 200-Day Moving Average 3 | 0.1494 |
Share Statistics
| Avg Vol (3 month) 3 | 15.26k |
| Avg Vol (10 day) 3 | 44.34k |
| Shares Outstanding 5 | 5.91M |
| Implied Shares Outstanding 6 | 5.91M |
| Float 8 | 5.72M |
| % Held by Insiders 1 | 3.22% |
| % Held by Institutions 1 | 0.00% |
| Shares Short (Mar 15, 2024) 4 | 1.07k |
| Short Ratio (Mar 15, 2024) 4 | 0.12 |
| Short % of Float (Mar 15, 2024) 4 | N/A |
| Short % of Shares Outstanding (Mar 15, 2024) 4 | 0.02% |
| Shares Short (prior month Feb 15, 2024) 4 | 235 |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:10 |
| Last Split Date 3 | Mar 01, 2024 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Nov 30, 2023 |
| Most Recent Quarter (mrq) | Nov 30, 2023 |
Profitability
| Profit Margin | -119.85% |
| Operating Margin (ttm) | -125.43% |
Management Effectiveness
| Return on Assets (ttm) | -33.54% |
| Return on Equity (ttm) | -64.49% |
Income Statement
| Revenue (ttm) | 250.32k |
| Revenue Per Share (ttm) | 0.04 |
| Quarterly Revenue Growth (yoy) | -100.00% |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -300k |
| Diluted EPS (ttm) | -0.0500 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 344.63k |
| Total Cash Per Share (mrq) | 0.06 |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 4.64 |
| Book Value Per Share (mrq) | 0.05 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -359.93k |
| Levered Free Cash Flow (ttm) | -251.78k |
© 2024 Yahoo. All rights reserved.